Sirtuin activators

锡尔图因 白藜芦醇 西妥因1 热卡限制 SIRT3 神经保护 药理学 NAD+激酶 激活剂(遗传学) 烟酰胺腺嘌呤二核苷酸 生物利用度 生物 辅活化剂 化学 受体 内分泌学 生物化学 转录因子 下调和上调 基因
作者
Francisco J. Alcaı́n,José M. Villalba
出处
期刊:Expert Opinion on Therapeutic Patents [Taylor & Francis]
卷期号:19 (4): 403-414 被引量:128
标识
DOI:10.1517/13543770902762893
摘要

Background: Sirtuin 1 – 7 (SIRT1 – 7) are deacetylases that are dependent on NAD+ for their activity. SIRT1 down-regulates p53 activity, increasing lifespan, cell survival, and neuroprotection; it also deacetylates peroxisome proliferator-activated receptor-γ and its coactivator 1α, promoting fat mobilization, increasing mitochondrial size and number, and positively regulating insulin secretion. Sirtuins link nutrient availability and energy metabolism. Calorie restriction, which increases lifespan and is beneficial in age-related disorders, activates sirtuin. Major efforts are thus focused to developing sirtuin activators. Objective: After discussing the potential involvement of sirtuins in pathophysiological processes, this review looks at new, synthetic sirtuin activators. Conclusions: To date, resveratrol is the most potent natural compound able to activate SIRT1, mimicking the positive effect of calorie restriction. Resveratrol might help in the treatment or prevention of obesity and in preventing the aging-related decline in heart function and neuronal loss. As resveratrol has low bioavailability and interacts with multiple molecular targets, the development of new molecules with better bioavailability and targeting sirtuin at lower concentrations is a promising field of the medicinal chemistry. New SIRT1 activators that are up to 1000 times more effective than resveratrol have recently been identified. These improve the response to insulin and increase the number and activity of mitochondria in obese mice. Human trials with a formulation of resveratrol with improved bioavailability and with a synthetic SIRT1 activator are in progress.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
书生应助科研通管家采纳,获得10
刚刚
shhoing应助科研通管家采纳,获得10
刚刚
1秒前
sylinmm应助科研通管家采纳,获得10
1秒前
书生应助科研通管家采纳,获得10
1秒前
1秒前
Jasper应助科研通管家采纳,获得10
1秒前
1秒前
1秒前
科研通AI2S应助科研通管家采纳,获得10
1秒前
AlinaLee应助科研通管家采纳,获得10
1秒前
书生应助科研通管家采纳,获得10
1秒前
科研通AI5应助科研通管家采纳,获得10
1秒前
无花果应助科研通管家采纳,获得50
1秒前
2秒前
thesunshine完成签到,获得积分20
3秒前
千空发布了新的文献求助20
3秒前
4秒前
4秒前
闪闪发布了新的文献求助10
7秒前
yayyaya发布了新的文献求助10
8秒前
七七发布了新的文献求助10
9秒前
呜呼啦呼完成签到,获得积分10
10秒前
10秒前
10秒前
10秒前
12秒前
啦啦啦发布了新的文献求助10
13秒前
17完成签到,获得积分10
14秒前
闪闪完成签到,获得积分20
14秒前
七月流火应助安生采纳,获得10
15秒前
潼熙甄完成签到 ,获得积分10
16秒前
易水寒完成签到,获得积分10
16秒前
Newky发布了新的文献求助10
16秒前
xyy9919发布了新的文献求助10
16秒前
milu223完成签到,获得积分10
17秒前
17秒前
zsh发布了新的文献求助10
17秒前
小蘑菇应助小李采纳,获得10
19秒前
科研顺利完成签到,获得积分10
21秒前
高分求助中
Production Logging: Theoretical and Interpretive Elements 2700
Neuromuscular and Electrodiagnostic Medicine Board Review 1000
こんなに痛いのにどうして「なんでもない」と医者にいわれてしまうのでしょうか 510
The First Nuclear Era: The Life and Times of a Technological Fixer 500
岡本唐貴自伝的回想画集 500
Distinct Aggregation Behaviors and Rheological Responses of Two Terminally Functionalized Polyisoprenes with Different Quadruple Hydrogen Bonding Motifs 450
Ciprofol versus propofol for adult sedation in gastrointestinal endoscopic procedures: a systematic review and meta-analysis 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 物理 生物化学 纳米技术 计算机科学 化学工程 内科学 复合材料 物理化学 电极 遗传学 量子力学 基因 冶金 催化作用
热门帖子
关注 科研通微信公众号,转发送积分 3670898
求助须知:如何正确求助?哪些是违规求助? 3227795
关于积分的说明 9777110
捐赠科研通 2937970
什么是DOI,文献DOI怎么找? 1609700
邀请新用户注册赠送积分活动 760446
科研通“疑难数据库(出版商)”最低求助积分说明 735947